HIV/AIDS Annual Surveillance Statistics

The following tables provide annual data on new diagnoses of HIV (non-AIDS), concurrent HIV/AIDS and AIDS, as well as the number of persons living with HIV and AIDS and the number of deaths among persons with HIV and AIDS. The data are shown for New York City overall and by sex, race, age, borough, area-based poverty level, risk factor, and United Hospital Fund neighborhood.


HIV/AIDS Annual Surveillance Tables (PDF)

Previous Years:

2019 | 2018 | 2017 | 2016 | 2015 | 2014 |2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 (PDFs)

Glance (Table 1.1) (PDF, one page)

Previous Years:

2019 | 2018 | 2017 | 2016 | 2015 | 2014 |2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 (PDFs, one page each)

Trends in the HIV/AIDS Epidemic, Pre-1981 to 2020 (PDF)


These tables will answer the majority of the most frequently asked questions about HIV in New York City. All percentages appearing in Tables 1.1 to 1.11.4 are column percentages except the total proportion of HIV diagnoses without AIDS and concurrent with AIDS diagnoses, which are row percentages of total HIV diagnoses. Because of rounding, percentages across categories may not sum to 100.0.

Categories containing any cells representing one to five people with an underlying denominator of ≤500 people or cells with a denominator ≤100, as per corresponding year intercensal population estimates, are collapsed into the Other/Unknown category. This collapsing of categories is not done in Table 1.1 (all of New York City), Table 1.2.1 (Men), and Table 1.2.2 (Women). Non-residential ZIP codes from the yearly intercensal estimates are excluded from borough-specific population totals but are included in the NYC overall population for the reported year.

For 2001-2010 tables, data are presented by sex at birth. For 2011-2020 tables, data are presented by gender. Surveillance collects information about individuals’ current gender identity, when available. These tables display the following gender categories: men, women and transgender. People whose current gender identity differs from their sex assigned at birth are considered transgender. Classifying transgender people in surveillance requires accurate collection of both sex assigned at birth and current gender identity. Sex and gender information are collected from people’s self-report, their diagnosing provider, or medical chart review. This information may or may not reflect the individual’s self-identification. Transgender identity has been collected routinely since 2005 for newly reported cases. Reported numbers of new transgender HIV diagnoses and transgender people living with HIV (PLWH) are likely to be underestimates. For more information, see the "HIV/AIDS among Transgender people in New York City" (PDF) surveillance slide set.

Surveillance collects information on other gender identity categories, including “Non-binary/Gender non-conforming.” In these tables, data for these individuals (N=8 at the time of publication) is displayed by sex at birth.

Data on race/ethnicity are derived from multiple sources including patient medical charts, provider reporting, vital statistics records, and patient interviews. Black, White, Asian/Pacific Islander, Native American, and Multiracial race categories exclude Latino/Hispanic ethnicity. Cases with the ethnicity Latino/Hispanic were grouped in the race/ethnicity category Latino/Hispanic, regardless of their race classification. For more information on race definitions, see Technical Notes on Race and Ethnicity Classification in NYC HIV Surveillance Data (PDF).

For 2008-2020 tables, residence is at diagnosis for HIV and AIDS diagnoses; for PLWH and deaths, residence is based on most recent record available or residence at death, respectively. For earlier years, residence is at diagnosis for HIV and AIDS diagnoses, and for PLWH and deaths residence is based on residence at AIDS diagnosis if surveillance status is AIDS or residence at HIV diagnosis if HIV-only. Tables for 2008-2020 include area-based poverty level, which is based on NYC ZIP code of residence at diagnosis or most recent record available. Poverty level is not available for people missing ZIP code information or living outside NYC.

If you are interested in additional analyses or have questions about the tables, email the HIV Epidemiology Program at

Suggested Citation

New York City HIV/AIDS Annual Surveillance Statistics. New York: New York City Department of Health and Mental Hygiene, 2020. Accessed [access date] at New York City HIV/AIDS Annual Surveillance Statistics.



Acute HIV Infection: revised June 2017 (PDF)


Acquired immunodeficiency syndrome


Human immunodeficiency virus


HIV-1 is the retrovirus that is responsible for the majority of cases in the world AIDS pandemic.


HIV-2 is a closely related but distinct virus that is found primarily in West Africa and countries with large West African immigrant populations.

See more in-depth information regarding HIV Type 2.


Injection drug use or injecting drug user


Men who have sex with men


People with HIV or AIDS


People living with HIV. For these tables, PLWH refers to people diagnosed and reported in New York City and presumed to be living with HIV.

UHF neighborhood:

United Hospital Fund neighborhood



Age is calculated as age at diagnosis for HIV and AIDS diagnoses; age as of the end of the calendar year for PLWH; and age at death for deaths.

AIDS diagnosis:

People are classified as having AIDS if they are living with HIV and either have one or more AIDS-defining opportunistic illnesses (based on the 1993 CDC case definition) or a laboratory test indicating suppressed CD4+ cell counts (<200 cells/µL).

Clinical status:

Clinical status is determined as of the end of the calendar year or at date of death.

Concurrent HIV/AIDS:

An AIDS diagnosis within 31 days of an HIV diagnosis. People concurrently diagnosed with HIV and AIDS are included in the totals of both HIV diagnoses and AIDS diagnoses.

HIV diagnosis:

A diagnosis of HIV is generally based on a positive multi-test algorithm (screening immunoassay, HIV-1/2 differentiation assay, and RNA test) in adults and a positive PCR (polymerase chain reaction) test in infants younger than 18 months. Since June 1, 2000, laboratories and health care providers in New York State have been required to report positive HIV test results even in people without AIDS.


Technical Notes on Race

Transmission risk:

HIV surveillance captures information about risk factors associated with HIV transmission.

The primary risk factors are men who have sex with men (MSM), injection drug use history (IDU), MSM-IDU, heterosexual contact, transgender people with sexual contact (TG-SC), and perinatal transmission.

Men who have sex with men includes men with reported sexual contact with another man, and men with no definitive risk and with history of a rectal STD or proctitis.

The injection drug use category includes people with a history of taking nonprescribed drugs by injection, intravenously, intramuscularly or subcutaneously, excluding men reporting a history of sex with men.

The men reporting a history of sex with men and injection drug use (MSM-IDU) category includes people meeting the definition of both the men who have sex with men and injection drug use categories as described.

The heterosexual contact category includes people who had heterosexual sex with a person they know to be living with HIV, a person who has injected drugs or a person who has received blood products. For women only, also includes history of sex work, multiple sex partners, sexually transmitted disease, crack/cocaine use, sex with a bisexual man, probable heterosexual transmission as noted in medical chart or sex with a man and negative history of injection drug use.

Transgender people with sexual contact includes people identified as transgender at any time by self-report, medical provider or chart review, or ongoing data collection with sexual contact reported and a negative history of injection drug use.

Perinatal transmission is a risk factor for infants who were exposed to HIV during gestation, birth or postpartum through breastfeeding to a mother living with HIV.

Other transmission risk includes people who received treatment for hemophilia, people who received a transfusion or transplant, people with other health care-associated transmission and children with non-perinatal transmission risk.

People with a risk that is unknown have no risk information reported by the provider or an expanded investigation has not been completed for them.

UHF neighborhood:

This corresponds to a geographic area within New York City that is an aggregate of between one and nine ZIP codes but is smaller than a borough. UHF neighborhoods reflect catchment areas for certain health care facilities. See the table and map of UHF neighborhoods and corresponding ZIP codes (PDF).